106 related articles for article (PubMed ID: 31791959)
1. Clonal Selection Drives NF-κB Activation in Recurrent Nasopharyngeal Carcinoma.
Sehgal K; Barbie DA
Cancer Res; 2019 Dec; 79(23):5915-5916. PubMed ID: 31791959
[TBL] [Abstract][Full Text] [Related]
2. Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma.
You R; Liu YP; Lin DC; Li Q; Yu T; Zou X; Lin M; Zhang XL; He GP; Yang Q; Zhang YN; Xie YL; Jiang R; Wu CY; Zhang C; Cui C; Wang JQ; Wang Y; Zhuang AH; Guo GF; Hua YJ; Sun R; Yun JP; Zuo ZX; Liu ZX; Zhu XF; Kang TB; Qian CN; Mai HQ; Sun Y; Zeng MS; Feng L; Zeng YX; Chen MY
Cancer Res; 2019 Dec; 79(23):5930-5943. PubMed ID: 31484669
[TBL] [Abstract][Full Text] [Related]
3. Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma.
Chung GT; Lou WP; Chow C; To KF; Choy KW; Leung AW; Tong CY; Yuen JW; Ko CW; Yip TT; Busson P; Lo KW
J Pathol; 2013 Nov; 231(3):311-22. PubMed ID: 23868181
[TBL] [Abstract][Full Text] [Related]
4. Rediscovery of NF-κB signaling in nasopharyngeal carcinoma: How genetic defects of NF-κB pathway interplay with EBV in driving oncogenesis?
Yi M; Cai J; Li J; Chen S; Zeng Z; Peng Q; Ban Y; Zhou Y; Li X; Xiong W; Li G; Xiang B
J Cell Physiol; 2018 Aug; 233(8):5537-5549. PubMed ID: 29266238
[TBL] [Abstract][Full Text] [Related]
5. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
[TBL] [Abstract][Full Text] [Related]
6. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
7. IKBB tumor suppressive role in nasopharyngeal carcinoma via NF-κB-mediated signalling.
Phoon YP; Cheung AK; Cheung FM; Chan KF; Wong S; Wong BW; Tung SY; Yau CC; Ng WT; Lung ML
Int J Cancer; 2016 Jan; 138(1):160-70. PubMed ID: 26227166
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200a mediates nasopharyngeal carcinoma cell proliferation through the activation of nuclear factor-κB.
Shi Z; Hu Z; Chen D; Huang J; Fan J; Zhou S; Wang X; Hu J; Huang F
Mol Med Rep; 2016 Feb; 13(2):1732-8. PubMed ID: 26718506
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide suppresses proliferation of nasopharyngeal carcinoma cells via attenuating NF-κB pathway.
Peng T; Hu M; Wu TT; Zhang C; Chen Z; Huang S; Zhou XH
Biomed Res Int; 2015; 2015():735056. PubMed ID: 25861643
[TBL] [Abstract][Full Text] [Related]
11. Effect of CRISPR/Cas9 system-mediated NF-κB knockdown on CNE-2 immune function in nasopharyngeal carcinoma.
Ren Y; Zhao Y; Sun W; Chen Y; Yang J; Li Z; Wu X; Zhao L; Sun W; Lv C; Huang N; Li X
J Biol Regul Homeost Agents; 2021 Aug; 35(4):. PubMed ID: 34337911
[No Abstract] [Full Text] [Related]
12. Parthenolide inhibits cancer stem-like side population of nasopharyngeal carcinoma cells via suppression of the NF-κB/COX-2 pathway.
Liao K; Xia B; Zhuang QY; Hou MJ; Zhang YJ; Luo B; Qiu Y; Gao YF; Li XJ; Chen HF; Ling WH; He CY; Huang YJ; Lin YC; Lin ZN
Theranostics; 2015; 5(3):302-21. PubMed ID: 25553117
[TBL] [Abstract][Full Text] [Related]
13. Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through a NF-κB-independent and ERK-dependent pathway.
Xie Y; Li Y; Peng X; Henderson F; Deng L; Chen N
Oral Oncol; 2013 Dec; 49(12):1113-20. PubMed ID: 24075781
[TBL] [Abstract][Full Text] [Related]
14. The Ras signaling pathway mediates cetuximab resistance in nasopharyngeal carcinoma.
Zuo Q; Shi M; Chen J; Liao W
Biomed Pharmacother; 2011 Jun; 65(3):168-74. PubMed ID: 21602020
[TBL] [Abstract][Full Text] [Related]
15. Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes.
Zhang L; MacIsaac KD; Zhou T; Huang PY; Xin C; Dobson JR; Yu K; Chiang DY; Fan Y; Pelletier M; Wang Y; Jaeger S; Krishnamurthy Radhakrishnan V; JeBailey L; Skewes-Cox P; Zhang J; Fang W; Huang Y; Zhao H; Zhao Y; Li E; Peng B; Huang A; Dranoff G; Hammerman PS; Engelman J; Bitter H; Zeng YX; Yao Y
Mol Cancer Res; 2017 Dec; 15(12):1722-1732. PubMed ID: 28851814
[TBL] [Abstract][Full Text] [Related]
16. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
17. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate inhibits nasopharyngeal cancer stem cell self-renewal and migration and reverses the epithelial-mesenchymal transition via NF-κB p65 inactivation.
Li YJ; Wu SL; Lu SM; Chen F; Guo Y; Gan SM; Shi YL; Liu S; Li SL
Tumour Biol; 2015 Apr; 36(4):2747-61. PubMed ID: 25487615
[TBL] [Abstract][Full Text] [Related]
19. Significance of NF-κB activation in immortalization of nasopharyngeal epithelial cells.
Zhu DD; Zhang J; Deng W; Yip YL; Lung HL; Tsang CM; Law WT; Yang J; Lau VM; Shuen WH; Lung ML; Cheung AL; Tsao SW
Int J Cancer; 2016 Mar; 138(5):1175-85. PubMed ID: 26370441
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
